from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1431/-

LFCtreatmentdescriptionclass of inhibitor

-0.502

Amikacinug/mL Amikacintranslation

-1.166

Cap5-10ug/mL Capreomycintranslation

-1.311

Rox10-50 ug/mL Roxithromycintranslation

-0.230

SM2-5 ug/mL Streptomycintranslation

-2.211

Tet5-10 ug/mL Tetracyclinetranslation

-0.394

Rif0.2-5ug/mL Rifampicintranscription

-0.205

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.787

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.248

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.884

CPZ10-50 ug/mL Chlorpromazinerespiration

0.774

Clofazimine10-13 ug/mL Clofaziminerespiration

0.989

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.589

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.825

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.357

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.820

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.950

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.203

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.657

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.472

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.790

KCN5-20 ug/mL Potassium cyaniderespiration

1.016

NaN30.2-2 mM Sodium aziderespiration

0.742

Nigericin50 uM Nigericinrespiration

0.127

TRC10-150 ug/mL Triclosanrespiration

1.223

TRZ10-25 ug/mL Thioridazinerespiration

-0.103

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.331

menadione6-10 ug/mL Menadionerespiration

0.435

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.134

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.043

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.161

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.212

NRP_1Non-replicating persistence stage 1dosRassociated

-0.441

Amp0.2mg/mL AmpicillincellWall

-0.057

Cephalexin20-100 ug/mL CephalexincellWall

-0.477

Cerulenin0.32-5 ug/mL CerulenincellWall

0.214

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.185

EMB10-20 ug/mL EthambutolcellWall

0.377

Eta12-40 ug/mL EthionamidecellWall

0.354

INH0.2-0.4 ug/mL IsoniazidcellWall

0.034

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.031

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.143

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.382

BZA0.12 mg/mL BenzamidearomaticAmides

-0.585

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.058

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.016

H2O24 mM hydrogen peroxideDNAdamaging

-0.037

Levo10 ug/mL LevofloxacinDNAdamaging

-0.696

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.279

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.245

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.442

UVUV-irradiationDNAdamaging

2.296

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.170

Antimycin12.5-50 ug/mL Antimycin A?

0.066

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.290

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.345

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.965

PA8240.2-2 ug/mL PA-824?

0.377

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.458

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.315

Verapamil50 uM Verapamil?

0.703

mercaptoethanol2 mM 2-Mercaptoethanol?

0.011

methoxatin10-20 ug/mL Methoxatin?